And a competitor nearer to home which is now listed on ASX - Fisher Paykel HealthCare (FPH) and also sells products into US markets. FPH also has a range of products not just ones focusing on sleep apnoea market so hence has a better potential all-around than a company just relying on one product (RMD)
Resmed, page-8
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$35.64 |
Change
0.200(0.56%) |
Mkt cap ! $21.85B | |||
| Open | High | Low | Value | Volume |
| $35.60 | $35.82 | $35.51 | $35.56M | 997.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $35.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $35.70 | 15 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| RMD (ASX) Chart |